Ep. 217 - David Moatazedi of Evolus | Live from AIS 2026

Live from AIS 2026 in Boston, Dr. Grant Stevens welcomes Evolus CEO David Moatazedi for a conversation about innovation, growth, and the future of injectable aesthetics. David discusses the successful launch of Evolysse™, a next-generation hyaluronic acid filler platform, and explains how its novel manufacturing process may help meet growing patient demand for more natural-looking outcomes. He also shares his perspective on market trends, the continued normalization of aesthetic treatments, ...